Amylyx Pharmaceuticals

Amylyx Pharmaceuticals is a biopharmaceutical company best known for AMX0035, an experimental therapy for amyotrophic lateral sclerosis.

Year Established: 2013 Stock Ticker: AMLX Exchange: NASDAQ

Locations